Detalles de la búsqueda
1.
Phase 2 trial of bintrafusp alfa as second-line therapy for patients with locally advanced/metastatic biliary tract cancers.
Hepatology
; 78(3): 758-770, 2023 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36999533
2.
Xevinapant plus radiotherapy in resected, high-risk, cisplatin-ineligible LA SCCHN: the phase III XRay Vision study design.
Future Oncol
; 20(12): 739-748, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38197296
3.
Long-term avelumab in advanced non-small-cell lung cancer: summaries and post hoc analyses from JAVELIN Solid Tumor.
Future Oncol
; 18(11): 1333-1342, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-35144482
4.
Health-related quality of life trajectory of treatment-naive patients with Merkel cell carcinoma receiving avelumab.
Future Oncol
; 16(27): 2089-2099, 2020 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-32938212
5.
Avelumab versus docetaxel in patients with platinum-treated advanced non-small-cell lung cancer (JAVELIN Lung 200): an open-label, randomised, phase 3 study.
Lancet Oncol
; 19(11): 1468-1479, 2018 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30262187
6.
Managing cisplatin-ineligible patients with resected, high-risk, locally advanced squamous cell carcinoma of the head and neck: Is there a standard of care?
Cancer Treat Rev
; 119: 102585, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37392723
7.
Comparison of tumor assessments using RECIST 1.1 and irRECIST, and association with overall survival.
J Immunother Cancer
; 10(2)2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35228264
8.
Impact of subsequent immune checkpoint inhibitor treatment on overall survival with avelumab vs docetaxel in platinum-treated advanced NSCLC: Post hoc analyses from the phase 3 JAVELIN Lung 200 trial.
Lung Cancer
; 154: 92-98, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33636453
9.
Avelumab for platinum-ineligible/refractory recurrent and/or metastatic squamous cell carcinoma of the head and neck: phase Ib results from the JAVELIN Solid Tumor trial.
J Immunother Cancer
; 9(10)2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34663640
10.
Avelumab Versus Docetaxel in Patients With Platinum-Treated Advanced NSCLC: 2-Year Follow-Up From the JAVELIN Lung 200 Phase 3 Trial.
J Thorac Oncol
; 16(8): 1369-1378, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33845211
11.
Efficacy and immune-related adverse event associations in avelumab-treated patients.
J Immunother Cancer
; 8(2)2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-33219092
12.
Efficacy and safety of first-line avelumab in patients with advanced non-small cell lung cancer: results from a phase Ib cohort of the JAVELIN Solid Tumor study.
J Immunother Cancer
; 8(2)2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32907924
13.
Avelumab in patients with previously treated metastatic Merkel cell carcinoma: long-term data and biomarker analyses from the single-arm phase 2 JAVELIN Merkel 200 trial.
J Immunother Cancer
; 8(1)2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32414862
14.
ACCELERATE and European Medicines Agency Paediatric Strategy Forum for medicinal product development of checkpoint inhibitors for use in combination therapy in paediatric patients.
Eur J Cancer
; 127: 52-66, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31986450
15.
Avelumab monotherapy as first-line or second-line treatment in patients with metastatic renal cell carcinoma: phase Ib results from the JAVELIN Solid Tumor trial.
J Immunother Cancer
; 7(1): 275, 2019 10 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-31651359
16.
Efficacy and Safety of First-line Avelumab Treatment in Patients With Stage IV Metastatic Merkel Cell Carcinoma: A Preplanned Interim Analysis of a Clinical Trial.
JAMA Oncol
; 4(9): e180077, 2018 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29566106
Resultados
1 -
16
de 16
1
Próxima >
>>